Article Text

Download PDFPDF

Ethical issues and best practice in clinically based genomic research: Exeter Stakeholders Meeting Report
  1. D Carrieri1,
  2. C Bewshea2,
  3. G Walker2,
  4. T Ahmad2,
  5. W Bowen3,
  6. A Hall4,
  7. S Kelly1
  8. on behalf of the 7th of October 2015 Exeter Stakeholders Meeting
  1. 1Egenis, Department of Sociology, Philosophy and Anthropology, University of Exeter, Exeter, UK
  2. 2IBD and Pharmacogenetics Research Group, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
  3. 3Health Research Authority, NHS, London, UK
  4. 4PHG Foundation, Cambridge, UK
  1. Correspondence to Dr D Carrieri, Department of Egenis, Sociology, Philosophy and Anthropology, University of Exeter, St German's Rd, Exeter EX4 4PJ, UK; d.carrieri{at}exeter.ac.uk

Abstract

Current guidelines on consenting individuals to participate in genomic research are diverse. This creates problems for participants and also for researchers, particularly for clinicians who provide both clinical care and research to their patients. A group of 14 stakeholders met on 7 October 2015 in Exeter to discuss the ethical issues and the best practice arising in clinically based genomic research, with particular emphasis on the issue of returning results to study participants/patients in light of research findings affecting research and clinical practices. The group was deliberately multidisciplinary to ensure that a diversity of views was represented. This report outlines the main ethical issues, areas of best practice and principles underlying ethical clinically based genomic research discussed during the meeting. The main point emerging from the discussion is that ethical principles, rather than being formulaic, should guide researchers/clinicians to identify who the main stakeholders are to consult with for a specific project and to incorporate their voices/views strategically throughout the lifecycle of each project. We believe that the mix of principles and practical guidelines outlined in this report can contribute to current debates on how to conduct ethical clinically based genomic research.

  • Clinical Ethics
  • Genethics
  • Patient perspective
  • Research Ethics
  • Regulation

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors All authors listed contributed to the drafting of the report. CB, GW, TA, DC and SK designed the original project and organised the stakeholder event.

  • Funding Economic and Social Research Council (Impact Accelerator Account SL-06879)

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Other content recommended for you